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Results: With DiBH there is an increase in treated lung 
volume, however it equates to a mean reduction in the 
overall percentage of lung treated. Although there appears to 
be a relationship between the V50%, V18Gy and CLD, initial 
results show that traditional CLD limits may not be as 
relevant when using DiBH. 
  
 
Conclusions: Overall, DiBH enables us to meet planning 
constraints more effectively and although DiBH increases the 
CLD or volume of lung in the field for nearly all cases this 
does not equate to an increase in the percentage of total 
lung irradiated. A CLD value can be used as a guide for field 
delineation however results suggest that volumetric 
information should be reviewed in all cases, particularly if 
target coverage will be compromised.  
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Purpose/Objective: External dosimetry audits are a key 
element of clinical trial QA programmes to minimise 
systematic discrepancies in treatment delivery having a 
detrimental impact on the trial question. Audits can be 
costly, time intensive and require dedicated staff expertise. 
A study was set-up to investigate whether remote evaluation 
methods along with appropriately executed in-house QA 
programmes could provide a feasible and acceptable 
alternative to external dosimetry audit visits in the context 
of VMAT delivery. 
Materials and Methods: Eight radiotherapy centres (nine 
linacs) were included, incorporating various combinations of 
delivery equipment and treatment planning systems (TPS). 
Each centre was asked to plan a complex planning case 
previously used in the UK National Rotational Radiotherapy 
Audit [1, 2] and up to two of the current Trans-Tasman 
Radiation Oncology Group (TROG) clinical trial benchmarking 
exercises (head and neck and/or prostate bed) for 
independent verification. The external dosimetry audit was 
performed with the PTW Octavius4D phantom and seven29 2D 
array. Plans were evaluated using absolute dose global 
gamma (γ) index calculations, with a 10% threshold and 
normalised to a point in a high dose, low dose gradient 
region. Prior to the external dosimetry audit, sites were 
asked to report the results of their in-house QA on all audit 
plans and describe their analysis methods. A third aspect of 
the study evaluated a software program (Mobius [3]) as a tool 
for independently calculating dose on DICOMRT plans and 
reconstructed MLC treatment delivery logs allowing remote 
evaluation of VMAT delivery. 
Results: The external dosimetry audit yielded results for both 
2D planar and full 3D dose comparison with the TPS. A 
summary of the mean gamma pass rates for a range of 
gamma criteria is presented in Table 1. 
 
 
A review of in-house QA programmes highlighted a wide 
variation in approach. All sites indicated that their in-house 
QA of the plans met minimum local criteria, while the 
external audit did not reveal any contradictory results. This is 
in contrast with a recent study which reported institutional 
patient-specific IMRT QA did not always predict unacceptable 
results [4]. The difference may be related to the prospective 
nature of the in-house QA in our study along with the small 
number of participating centres. Gamma pass rates ranged 
from 89.5 - 100% (mean = 98.0%) and 63.1 - 99.3% (mean = 
87.2%) for 3%/3mm and 2%/2mm respectively for the plans 
calculated with Mobius, while greater variation in results 
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were observed for the reconstructed dose distributions based 
on the MLC logs. 
Conclusions: All participating sites demonstrated acceptable 
implementation of VMAT delivery achieving 3%/3mm γ pass 
rates > 90% for the external dosimetry audit. The reported in-
house QA results were consistent with the audit despite 
differences in dosimetry equipment and analysis methods. 
Mobius provided remote data analysis for independent 
assessment of TPS dose calculation and VMAT delivery. 
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Purpose/Objective: To demonstrate the utility of complexity 
metrics such as the modulation complexity score (MCS) and 
monitor units (MU) in multi-institutional audits of VMAT 
treatment delivery. 
Materials and Methods: 39 VMAT treatment plans from 34 UK 
radiotherapy centres were analysed using MCS and MU. A 
virtual phantom planning exercise (3DTPS plan [1]) was 
planned and independently measured in each institution 
using the PTW Octavius phantom and PTW seven29 2D Array 
combination [2-3]. The global gamma index with a 20% 
threshold relative to a point selected in a high-dose, low-
gradient region, was used to compare the measured and 
predicted dose distributions. MCS and MU were compared to 
the average gamma index pass rates (2%2mm & 3%3mm) of 
the plans in two coronal planes and a sagittal plane. The TPS 
were grouped according to whether VMAT modelling had 
been specifically designed for the linac manufacturer’s own 
treatment delivery system (Type 1: Eclipse) or had been 
designed to be independent of vendor or VMAT delivery (Type 
2: Monaco, OMP and Pinnacle). Differences in plan 
complexity (MCS and MU) between treatment planning system 
types were compared using a student t-test. Correlations 
were made between the metrics and gamma pass rate using 
Pearson correlations. Statistical significance was set at 
p<0.05. 
Results: Table 1 shows that MCS and MU were significantly 
correlated with gamma pass rate when all 39 linac / 
treatment planning system (TPS) combinations were 
analysed. For Varian linear accelerators, significant 
correlations were observed for both MCS and MU compared 
with gamma pass rates. No correlation was observed between 
complexity metrics and the pass rates for Elekta linear 
accelerators. This may have been due to the fact that all 
Elekta linacs used Type 2 treatment planning systems. Type 2 
planning systems created more complex plans with 
significantly lower MCS (p<0.001) and significantly higher MUs 
(p=0.018) compared to Type 1 planning systems. ?Figure 1 
shows a statistically significant correlation was observed 






Conclusions: MU and MCS can be used as surrogate for 
complexity under audit conditions. MU and MCS provide a 
useful guide of how complex a plan is and these give some 
indication of plan deliverability.  
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